Connect with us

Special

Fertility treatment and family planning: what a lawyer wants you to know

By Janene Oleaga, family formation attorney at Oleaga Law LLC

Published

on

Janene Oleaga, family formation attorney at Oleaga Law LLC

Janene Oleaga, family formation attorney at Oleaga Law LLC, shares with us the legal issues you might want to consider before undergoing fertility treatment.

Millennial and Gen Z women are seeking fertility treatments in record numbers. According to the CDC, in 2019 approximately 12.2 per cent of women aged 15-49 had received some form of fertility treatment.

This statistic is steadily growing due in part to increased awareness of assisted reproductive technology and accessibility of fertility treatment options.

Whether you are pursuing IVF, egg banking, or other assisted reproductive technology, you need to give careful thought to the future of your genetic material. If you are pursuing fertility treatments in 2023 and beyond, here’s what you need to think about:

Egg cryopreservation

If you choose to cryopreserve your eggs to keep your future family building options open, you have countless choices regarding fertility clinics and egg preservation programs.

New fertility clinics like Kindbody and combination egg preservation/donation programs like Cofertlity offer a variety of options for women to freeze and store their eggs until and if they are ready for future use. Each programme has different costs and different policies regarding storage.

Review all consent forms carefully before moving forward and always consult with an experienced assisted reproduction attorney before entering into an egg donation arrangement.

Sperm donation

Successful sperm donation arrangements between single women and sperm donors, lesbian couples and sperm donors, and cis-hetero couples and sperm donors, are increasingly common reproductive arrangements. While you have the option to obtain sperm from a sperm bank, more commonly women are choosing to work with a known donor (also known as a “directed donor”).

Requirements surrounding the legalities of sperm donation vary from state to state and clinic to clinic and consulting with an assisted reproduction attorney early in the process can save you from complications down the road.

You and your donor will need a legal contract, called a sperm donation agreement, that clearly indicates your donor’s donative intent, sets forth the obligations and rights of each party, establishes you as the exclusive legal parent or parents of the child and protects the donor’s status as a donor only and not a legal parent.

Your legal contract can also address important topics such as compensation, confidentiality, and future contact.

Embryo creation

If you are undergoing IVF with a partner, whether with your previously frozen eggs or through a future egg retrieval procedure, the goal is to create viable embryos for use in your family building.

Before you give yourself the first shot of Lupron, your selected fertility clinic is going to present you with lengthy intake and consent forms. These forms ask important questions relating to your medical history and family building goals and also inquire as to what you desire to happen to your embryos in the event of the death or divorce of you and your partner.

You may be inclined to breeze through these forms without much thought, but your answers can have long-lasting consequences.

It’s expected that divorce and family courts will make custody determinations involving minor children and distribute marital property between divorcing spouses, but battles over who gets the embryos are becoming increasingly common. In New York, the court in Kass v. Kass, decided the fertility clinic forms completed by the divorcing couple was determinative as to which party would get the embryos.

While this strict contractual approach provides legal clarity, it gives a lot of weight to decisions made during the early stages of IVF when most couples are not adequately counselled and prepared to make decisions about their future reproductive material.

Other states have decided differently on the question of who gets the embryos, ranging from a balancing test weighing one party’s right not to procreate against the other party’s right to procreate, to a test of “contemporaneous mutual consent”, requiring agreement of the parties as to the disposition of the embryos.

While a prenuptial agreement can address how to classify and distribute your marital property, in the context of IVF an embryo disposition agreement has a similar purpose: avoiding lengthy and costly litigation in the future.

Couples with joint dispositional control of cryopreserved embryos can enter into an embryo disposition agreement, a legally binding contract, addressing the transfer of legal rights and dispositional control of their embryos upon some future event, such as their death or divorce, in addition to who would be a legal parent of any resulting children.

The legislature in at least one state (New York) has enacted a statute suggesting their desire for people to enter into these contracts to prevent tough decisions about procreative liberty from being made by a judge in the context of a divorce.

If you are pursuing IVF with your partner, it’s a good time to seek counsel and ensure your future right to procreate with your embryos is protected regardless of a change in your marital status or life circumstances.

Janene Oleaga is a fertility lawyer and reproductive rights advocate for LGBTQ+ individuals and couples navigating infertility. She founded her law practice, Oleaga Law LLC, to provide legal guidance in matters relating to surrogacy, egg donation, sperm donation, embryo donation and adoption. An advocate for pro-family legislation at the state and federal levels, Oleaga works with Resolve, Resolve New England and GLAD in support of legislation impacting the future of family formation law. 

Special

Jill Biden visits Imperial on women’s health and AMR mission

Published

on

Former US first lady Dr Jill Biden visited Imperial College Healthcare NHS Trust and Imperial College London to explore work on women’s health and antimicrobial resistance.

The visit was hosted by professor the Lord Darzi of Denham, who chairs the Fleming Initiative and directs Imperial’s Institute of Global Health Innovation.

Dr Biden, chair of the Milken Institute’s Women’s Health Network, spoke about the impact scientists, clinicians, innovators and investors can have on improving women’s healthcare.

Dr Biden stressed the importance of “collaboration, prevention and education” in improving women’s health globally.

At the museum, Dr Biden and Esther Krofah, executive vice-president of health at the Milken Institute, heard about the worldwide significance of the discovery and the contribution of women who, during wartime Britain, grew penicillin in bedpans to support early experimentation.

The discussion also explored how AMR is a key women’s health issue, with women disproportionately affected in low and middle-income countries, and in high-income settings where women are more likely than men to be prescribed antibiotics.

Dr Biden was shown an architectural model of the Fleming Centre in Paddington, which will bring together research, policy and public engagement to address AMR worldwide.

The second part of the visit brought together Imperial clinicians, researchers and innovators for a roundtable on women’s health priorities, including improving diagnosis, equity in maternity care and support during the menopause transition.

Participants highlighted wide variation in the quality of care for conditions affecting women and called for fairer access to services, with the postcode lottery named as a priority to address.

Professor Tom Bourne, consultant gynaecologist and chair in gynaecology at Imperial’s Department of Metabolism, Digestion and Reproduction, described how AI could improve diagnostic accuracy for conditions such as endometriosis.

Equity emerged as a central theme.

Professor Alison Holmes, professor of infectious diseases at Imperial College London and director of the Fleming Initiative, highlighted persistent gaps in women’s representation in clinical trials, including antibiotic studies, which limits the ability to optimise care and treatments.

Dr Christine Ekechi, consultant obstetrician and gynaecologist at Imperial College Healthcare NHS Trust, drew on national maternity investigations to underline the importance of valid data, meaningful engagement with affected communities and rebuilding trust.

Menopause and midlife health were also identified as priorities for clinical research.

Professor Waljit Dhillo, consultant endocrinologist and professor of endocrinology and metabolism in Imperial’s Department of Metabolism, Digestion and Reproduction, described a new treatment for hot flushes, including for women unable to take hormone replacement therapy, such as those with a history of breast cancer.

The discussion then turned to bringing innovation into health systems. Innovators shared how data and technology are being used to close gaps in women’s health, while noting challenges in accessing funding to grow and scale.

Dr Helen O’Neill and Dr Deidre O’Neill, co-founders of Hertility Health, described predictive algorithms using self-reported data to help diagnose gynaecological conditions at scale.

Embedded into clinical workflows, the technology could reduce waiting times, identify conditions earlier and improve outcomes. They noted how “we have cures for the rarest genetic conditions but don’t even have the answers to common women’s health issues.”

Dr Lydia Mapstone, Dr Tara O’Driscoll and Dr Sioned Jones, co-founders of BoobyBiome, outlined work creating products that harness beneficial bacteria found in breast milk to support infant health.

By isolating and characterising key microbial strains, BoobyBiome has created synbiotics, combinations of beneficial bacteria and the food that nourishes them, to make these benefits accessible to all babies.

Speakers throughout the visit stressed the need to reduce variation in care quality and outcomes for women, strengthen prevention and education, and address power and equity in women’s health.

Professor the Lord Ara Darzi said: “It was a privilege to welcome Dr Biden and the Milken Institute to Imperial to meet some of the outstanding researchers, clinicians and innovators advancing women’s health.

“Imperial’s unique combination of clinical excellence and world-leading research positions us at the forefront of tackling the biggest health challenges facing society and the UK’s ambition for innovation demands nothing less.

“For too long, the health needs of women and girls across their life course have not received the attention they deserve.

“By working together across borders and disciplines, we can transform equitable access to care, accelerate the detection and treatment of disease, and ultimately improve health outcomes for millions of women in the UK and around the world.”

Continue Reading

Special

AHA campaign to raise awareness of heart disease in women

Published

on

Fashion, beauty and lifestyle retailers have joined the American Heart Association to raise awareness of heart disease in women.

The Go Red. Shop with Heart. campaign launched at the New York Stock Exchange on 30 January.

Retailers will ask for donations at checkout in February or donate a percentage of proceeds from selected items.

More than four in 10 women in the US have some form of cardiovascular disease, a term for heart and blood vessel conditions such as heart disease and stroke.

Heart disease and stroke kill more women in the US each year than all forms of cancer combined.

Brands taking part include Away, Commando, Lafayette 148, Michael Kors, Reebok, ShopSimon.com, Summersalt, Torrid and White & Warren.

More than 40 other nationwide retailers are also inviting customers to support the organisation this February through its Life Is Why campaign.

Nancy Brown is chief executive officer of the American Heart Association.

She said: “Nearly 1 in 3 women die from cardiovascular disease each year, yet women are still profoundly under-represented in the clinical research, science and medicine that could save their lives.

“Retailers and consumers are uniquely positioned to turn everyday moments into meaningful change through Go Red. Shop with Heart.”

According to the American Heart Association 2026 Heart Disease and Stroke Statistics Update, heart disease is the leading cause of death in the US and stroke is the number four cause of death.

The organisation projects that at least six in 10 US adults will have cardiovascular disease within the next 30 years and related costs are expected to triple.

However, approximately 80 per cent of cardiovascular disease is preventable through lifestyle changes.

Mindy Grossman is a volunteer board member at the American Heart Association and partner and vice chair of Consello.

Grossman said: “Retail has always been a powerful connector.

“Shop with Heart gives our industry a shared platform to lead with purpose and unite consumers in support of heart health.”

Continue Reading

News

Milken launches women’s health network platform

Published

on

Milken Institute has launched the Women’s Health Network digital platform with Velir x Brooklyn Data to speed collaboration and investment across research, care and technology.

The new website creates a hub for members to share content, connect and coordinate projects, with branding and the first public Drupal build delivered by Velir x Brooklyn Data. A launch video premiered on 4 November 2025 at the inaugural steering committee and member luncheon in Washington DC, then featured at the Milken Institute Future of Health Summit.

Phase two is scheduled for February 2026, adding member log-ins for networking and content exchange. Phase three in April 2026 will add advanced collaboration tools and expanded community features.

“This launch represents the type of mission-driven, cross-sector digital work we are incredibly proud to support,” said Eliza Pare, vice-president of client services at Velir. “The Women’s Health Network is poised to transform collaboration in women’s health, and we’re honoured to help build the digital infrastructure that will make that possible.”

Chaired by former first lady Dr Jill Biden, the Women’s Health Network brings together leaders from industry, startups, investors, health systems, patient groups, academia and philanthropy. More than 100 members have joined, with a steering group that includes organisations such as the American Cancer Society, American Heart Association, Amgen, Deloitte, GE Healthcare, Merck, Microsoft, Northwell Health, Organon and others.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.